Stratasys (SSYS)
(Real Time Quote from BATS)
$8.88 USD
+0.02 (0.23%)
Updated Jul 26, 2024 03:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SSYS 8.88 +0.02(0.23%)
Will SSYS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SSYS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SSYS
Implied Volatility Surging for Stratasys (SSYS) Stock Options
Stratasys (SSYS) Launches New Dental 3D Printer DentaJet XL
SSYS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Stratasys (SSYS) Down 7% Since Last Earnings Report: Can It Rebound?
Stratasys (SSYS) Tests 3D Printed Models in Orthopedic Oncology
Stratasys (SSYS), AM Craft to Venture Into the Aviation Industry
Other News for SSYS
Stratasys unveils the DentaJetâ„¢ XL solution, designed to transform production of high-quality models for crowns and bridges, implants, clear aligner arches, and surgical guides
Stratasys Recognized at AMGTA Member Summit with Four Awards for Excellence in Additive Manufacturing Sustainable Business Practices
First patient enrolled in landmark clinical study to assess 3D printed models for orthopedic tumor removal
First Patient Enrolled in Landmark Clinical Study to Assess3D Printed Models for Orthopedic Tumor Removal
Stratasys enrolls first patient in orthopedic oncology 3D printed model study